BlueLinx Completes Acquisition of Cedar Creek
Apr 16, 2018 11:03 am UTC| Business
ATLANTA and OKLAHOMA CITY, April 16, 2018 -- BlueLinx (NYSE:BXC), a leading distributor of building and industrial products in the United States, today announced that it has completed its previously announced...
Apr 16, 2018 11:03 am UTC| Business
DETROIT, April 16, 2018 -- The Detroit Tigers will present the seventh annual Pink Out the Park on Mother’s Day, Sunday, May 13, when the Tigers face the Mariners at Comerica Park at 1:10 p.m. This special partnership...
Apr 16, 2018 11:01 am UTC| Business
Geneva, Switzerland and Boston, MA - April 16, 2018- ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that...
Celldex’s METRIC Study in Metastatic Triple-negative Breast Cancer Does Not Meet Primary Endpoint
Apr 16, 2018 11:01 am UTC| Business
HAMPTON, N.J., April 16, 2018 -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported that the Company’s randomized, Phase 2b METRIC Study of glembatumumab vedotin compared to Xeloda® (capecitabine) in patients with...
Apr 16, 2018 11:01 am UTC| Business
BERKELEY HEIGHTS, N.J., April 16, 2018 -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral therapies that target the various phases...
Apr 16, 2018 11:01 am UTC| Business
NEW YORK, April 16, 2018 -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, today announced expansion of its Board of Directors to include...
Apr 16, 2018 11:01 am UTC| Business
EXTON, Pa., April 16, 2018 -- Idera Pharmaceuticals, Inc. (“Idera”) (NASDAQ:IDRA), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel oligonucleotide...